Arf6: a new player in FcgammaRIIIA lymphocyte-mediated cytotoxicity.

Blood

Department of Experimental Medicine and Pathology, Istituto Pasteur-Fondazione Cenci-Bolognetti, University La Sapienza, viale Regina Elena, 324, 00161 Rome, Italy.

Published: July 2005

The activation of phosphoinositide metabolism represents a critical step in the signaling pathways leading to the activation of cytolytic machinery, but its regulation is partially understood. We report here that the stimulation of the low-affinity receptor for immunoglobulin G (IgG) (FcgammaRIIIA, CD16) on primary human natural killer (NK) cells induces a phosphatidylinositol 3-kinase (PI3K)-dependent activation of the small G protein Arf6. We first demonstrate a functional role for Arf6-dependent signals in the activation of the antibody-dependent cellular cytotoxicity (ADCC) attributable to the control of secretion of lytic granule content. We also show that Arf6 couples CD16 to the lipid-modifying enzymes phosphatidylinositol4phosphate 5-kinase type I alpha (PI5KIalpha) and phospholipase D (PLD) that are involved in the control of granule secretion; Arf6, but not Rho family small G proteins RhoA and Rac1, is required for receptor-induced PI5KIalpha membrane targeting as well as for PI5KIalpha and PLD activation. Our findings suggest that Arf6 plays a crucial role in the generation of a phosphatidylinositol4,5-bisphosphate (PIP2) plasma membrane pool required for cytolytic granule-mediated target cell killing.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-10-4100DOI Listing

Publication Analysis

Top Keywords

arf6
5
activation
5
arf6 player
4
player fcgammariiia
4
fcgammariiia lymphocyte-mediated
4
lymphocyte-mediated cytotoxicity
4
cytotoxicity activation
4
activation phosphoinositide
4
phosphoinositide metabolism
4
metabolism represents
4

Similar Publications

Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives.

Cancers (Basel)

December 2024

Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0818, Japan.

Cancer has long been believed to be a genetic disease caused by the accumulation of mutations in key genes involved in cellular processes. However, recent advances in sequencing technology have demonstrated that cells with cancer driver mutations are also present in normal tissues in response to aging, environmental damage, and chronic inflammation, suggesting that not only intrinsic factors within cancer cells, but also environmental alterations are important key factors in cancer development and progression. Pancreatic cancer tissue is mostly comprised of stromal cells and immune cells.

View Article and Find Full Text PDF

The medial overall survival is low in patients with gastric cancer (GC) at advanced stage, in which drug resistance plays an important role. β-elemene has been established as the suppressed role on GC cell proliferation, however, the concrete mechanism of it remains unclear in cisplatin (DDP)-resistance GC. Cell counting kit-8 (CCK8) assay was used to measure the half maximal inhibitory concentration (IC) values of DDP in DDP-resistance GC cell lines.

View Article and Find Full Text PDF

ARF6 as a Novel Activator of HIF-2α in Pulmonary Arterial Hypertension.

Am J Respir Cell Mol Biol

November 2024

Imperial College London, London, United Kingdom of Great Britain and Northern Ireland.

Article Synopsis
  • ARF6, a GTPase linked to cancer metastasis, is activated in lung endothelial cells during pulmonary arterial hypertension (PAH) and influences several key biological pathways.
  • Proteomic analysis of human pulmonary artery endothelial cells revealed that active ARF6 is associated with increased expression of hypoxia-inducible factor (HIF-2), essential for PAH, while showing lesser impact on HIF-1.
  • A novel ARF6 inhibitor, chlortetracycline (CTC), demonstrated potential in reducing HIF-2 activation and mitigating symptoms of PAH, indicating a new therapeutic approach that may target this pathway for better management of the disease.
View Article and Find Full Text PDF

Schwann cells are glial cells in the peripheral nervous system (PNS); they wrap neuronal axons with their differentiated plasma membranes called myelin sheaths. Although the physiological functions, such as generating saltatory conduction, have been well studied in the PNS, the molecular mechanisms by which Schwann cells undergo their differentiation program without apparent morphological changes before dynamic myelin sheath formation remain unclear. Here, for the first time, we report that Arf6, a small GTP/GDP-binding protein controlling morphological differentiation, and the guanine-nucleotide exchange factors cytohesin proteins are involved in the regulation of Schwann cell differentiation marker expression in primary Schwann cells.

View Article and Find Full Text PDF

Rab11 family interacting protein 4 (Rab11-FIP4) regulates endocytic trafficking. A possible role for Rab11-FIP4 in the regulation of lysosomal function has been proposed, but its precise function in the regulation of cellular homeostasis is unknown. By mRNA array and protein analysis, we found that Rab11-FIP4 is downregulated in the lysosomal storage disease cystinosis, which is caused by genetic defects in the lysosomal cystine transporter, cystinosin.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!